Yes, fibroid recurrence after myomectomy is well-documented and estimated at 15-30% within 3 years when root causes are not addressed
Tirzepatide: Another Relevant Comparison Tirzepatide (Mounjaro/Zepbound), a dual GIP/GLP-1 agonist approved by the FDA, provides another useful reference point
Factors associated with early failure of arteriovenous fistulae for haemodialysis access
Reported activities include fibroblast stimulation, controlled intracellular copper delivery, modulation of collagen and glycosaminoglycan synthesis, and broad changes in gene expression across stress-response and tissue-repair networks
Dichtel LE, Corey KE, Misdraji J, et al
Following this, the gel was rinsed twice with deionized water and incubated with 0.01% of l-DOPA at 37 C for 4 h for the development of dark-brown color bands by the enzymatic activity of the mh-Tyr